A functionally distinct member of the DP family of E2F subunits

Oncogene

Volumn 25, Issue 22, 2006, Pages 3212-3218

  Milton, A ^a   Luoto, K ^a   Ingram, L ^a   Munro, S ^a   Logan, N ^a   Graham, A L ^a   Brummelkamp, T R ^b   Hijmans, E M ^b   Bernards, R ^b   La Thangue, N B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cancer; Cell cycle; DP; E2F

Indexed keywords

DNA; HETERODIMER; PROTEIN; PROTEIN DP 4; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DNA BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; CARRIER PROTEINS; CELL CYCLE; CLONING, MOLECULAR; DIMERIZATION; E2F TRANSCRIPTION FACTORS; HUMANS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; OSTEOSARCOMA; PROTEIN SUBUNITS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

MAMMALIA;

EID: 33745060148     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209343     Document Type: Article

References (20)

1. Allen KE, de la Luna S, Kerkhoven RM, Bernards R, La Thangue NB. (1997). J Cell Sci 110: 2819-2831.
2. Bandara LR, Lam EWF, Sorensen TS, Zamanian M, Girling R, La Thangue NB. (1994). EMBO J 13: 3104-3114.
3. de la Luna S, Allen KE, Mason SL, La Thangue NB. (1999). EMBO J 18: 212-228.
4. de la Luna S, Burden MJ, Lee C-W, La Thangue NB. (1996). J Cell Sci 109: 2443-2452.
5. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin Jr WG, Livingston DM et al. (1996). Cell 85: 549-561.
6. Frolov MV, Dyson NJ. (2004). J Cell Sci 117: 2173-2181.
7. Girling R, Partridge JF, Bandara LR, Burden N, Totty NF, Hsuan JJ et al. (1993). Nature 362: 83-87.
8. Khon MJ, Leung S, Criniti V, Agromayor M, Yamasaki L. (2004). Mol Cell Biol 24: 7197-7205.
9. Kohn MJ, Bronson RT, Harlow E, Dyson NJ, Yamasaki L. (2003). Development 130: 1295-1305.
10. Krek W, Ewen ME, Shirodker S, Arany Z, Kaelin WF, Livingston DM. (1994). Cell 78: 161-172.
11. Logan N, Delavaine L, Graham A, Reilly C, Wilson J, Brummelkamp TR et al. (2004). Oncogene 23: 5138-5150.
12. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y. (2002). Science 296: 1132-1136.
13. Ormondroyd E, de la Luna S, La Thangue NB. (1995). Oncogene 11: 1437-1446.
14. Rogers KT, Higgins PDR, Milla MM, Phillips RS, Horowitz JM. (1996). Proc Natl Acad Sci USA 93: 7594-7599.
15. Stevens C, La Thangue NB. (2003). Arch Biochem Biophys 412: 157-169.
16. Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L, Jacks T. (1998). Mol Cell 2: 293-304.
17. Yamasaki L, Bronson R, Williams BO, Dyson N, Harlow E, Jacks T. (1998). Nat Genet 18: 360-364.
18. Zhang Y, Chellappan SP. (1995). Oncogene 10: 2085-2093.
19. Zheng N, Fraenkel E, Pabo CO, Pavletich NP. (1999). Genes Dev 13: 666-674.
20. Zhu W, Giangrande PH, Nevins JR. (2004). EMBO J 23: 4615-4626.